Javara Inc. and Wake Forest Baptist Health Partner to Amplify Trial Access
Javara Inc. and Wake Forest Baptist Health have signed an Integrated Research Agreement which extends their existing partnership to provide clinical research services at the point of care with physicians and patients within Wake Forest Baptist Health’s community health care clinics and designated medical centers. This agreement forms a relationship between the Wake Forest Baptist Health system and Javara’s research team to provide clinical research as a care option extends to patients across the 24 counties that Wake Forest Baptist serves.
Expanded clinical trial operations between Javara and Wake Forest Baptist are expected to begin in May 2021.
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
